REPORT ATTRIBUTE |
DETAILS |
Historical Period |
2019-2022 |
Base Year |
2023 |
Forecast Period |
2024-2032 |
U.S. Peripheral Vascular Devices Market Size 2023 |
USD 2,945.00 Million |
U.S. Peripheral Vascular Devices Market, CAGR |
6.70% |
U.S. Peripheral Vascular Devices Market Size 2032 |
USD 4,947.26 Million |
Market Overview
The U.S. Peripheral Vascular Devices Market is projected to grow from USD 2,945.00 million in 2023 to USD 4,947.26 million by 2032, at a compound annual growth rate (CAGR) of 6.70%.
The U.S. Peripheral Vascular Devices market is driven by the rising prevalence of peripheral artery diseases (PAD) and the increasing geriatric population, which are major risk factors for vascular disorders. Technological advancements, such as minimally invasive procedures and improved device designs, are enhancing the efficacy and safety of treatments, contributing to market growth. Additionally, the growing focus on early diagnosis and preventive care is expanding the adoption of peripheral vascular devices. Trends such as the increasing popularity of bioresorbable devices and the shift towards outpatient settings for vascular procedures are further shaping the market. The integration of advanced materials and the development of next-generation stents and catheters are expected to boost treatment outcomes, fostering further market expansion. Furthermore, supportive reimbursement policies and growing healthcare investments are creating a conducive environment for the widespread adoption of these devices. These factors combined are likely to fuel the market’s growth in the coming years.
The U.S. Peripheral Vascular Devices market exhibits strong regional demand, driven by healthcare infrastructure, aging populations, and rising incidences of vascular diseases such as peripheral artery disease (PAD). Key players in the market include Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, and Becton, Dickinson and Company, among others. These companies are leading innovation in vascular device technologies, offering a range of products such as angioplasty balloons, stents, catheters, and guidewires. They are focused on expanding their presence across the U.S. through partnerships, acquisitions, and a strong emphasis on research and development. Additionally, the increasing adoption of minimally invasive procedures in hospitals, ambulatory surgical centers, and specialty clinics is accelerating the demand for these devices. With ongoing advancements and a competitive landscape, key players are strategically positioning themselves to capture the growing market for peripheral vascular devices in the U.S.
Access crucial information at unmatched prices!
Request your free sample report today & start making informed decisions powered by Credence Research!
Download Free Sample
Market Insights
- The U.S. Peripheral Vascular Devices market was valued at USD 2,945.00 million in 2023 and is expected to reach USD 4,947.26 million by 2032, growing at a CAGR of 6.70%.
- Increasing adoption of minimally invasive procedures is driving market growth, as patients and healthcare providers seek less invasive treatment options.
- Growing prevalence of peripheral artery disease (PAD) and lifestyle-related risk factors like obesity and diabetes is fueling demand for vascular interventions.
- The shift toward outpatient and ambulatory care centers is accelerating the adoption of peripheral vascular devices, offering cost-effective alternatives.
- Technological advancements, such as drug-eluting stents and bioresorbable devices, are enhancing treatment efficacy and patient outcomes.
- Key players like Abbott Laboratories, Boston Scientific Corporation, and Medtronic plc dominate the competitive landscape, focusing on innovation and strategic partnerships.
- Market restraints include the high cost of advanced devices and regulatory challenges, which may limit access and adoption across certain patient populations.
Market Drivers
Technological Advancements in Medical Devices
Technological innovation is another key factor driving the growth of the U.S. Peripheral Vascular Devices market. Advancements in device design, such as the development of drug-eluting stents, bioresorbable vascular scaffolds, and advanced catheters, are enhancing treatment outcomes and patient safety. For instance, the development of the Shockwave Javelin Peripheral IVL Catheter has shown positive clinical results for treating calcified lesions in PAD. Minimally invasive techniques have become more common, reducing recovery time and improving patient satisfaction. These innovations are leading to the widespread adoption of vascular devices for treating various peripheral vascular diseases, thus contributing to market expansion.
Aging Population and Rising Healthcare Expenditures
The aging U.S. population is a significant driver of the peripheral vascular device market. As the number of elderly individuals increases, so does the incidence of age-related vascular diseases. For instance, by 2034, Americans aged 65 and older will exceed 77 million. Older adults are more susceptible to conditions like PAD, which in turn fuels the demand for peripheral vascular interventions. Furthermore, increased healthcare expenditures and better access to healthcare services have improved the availability and adoption of these devices, making them more accessible to a larger patient population and driving market growth.
Growing Prevalence of Peripheral Artery Disease (PAD)
One of the primary drivers of the U.S. Peripheral Vascular Devices market is the increasing incidence of peripheral artery disease (PAD). As a condition predominantly affecting the elderly and those with risk factors like diabetes, hypertension, and smoking, PAD is contributing significantly to the demand for vascular interventions. With PAD affecting millions of Americans, the need for effective treatments such as stents, balloons, and catheters is rising. As the disease continues to spread, the market for peripheral vascular devices is expected to expand steadily.
Supportive Reimbursement Policies
Supportive reimbursement policies play a crucial role in driving the U.S. Peripheral Vascular Devices market. As insurers and government programs like Medicare expand coverage for peripheral vascular treatments, more patients are able to access these life-changing procedures. For example, the Centers for Medicare & Medicaid Services (CMS) has made significant changes to reimbursement policies, increasing coverage for various peripheral vascular procedures. The financial support from insurance programs has made vascular device procedures more affordable for a broader segment of the population. This increase in insurance coverage and reimbursement rates is expected to drive greater adoption and utilization of peripheral vascular devices, thus positively impacting market growth.
Market Trends
Shift Toward Minimally Invasive Procedures
A significant trend in the U.S. Peripheral Vascular Devices market is the growing preference for minimally invasive procedures. These procedures offer patients reduced recovery times, smaller incisions, and lower risk of complications compared to traditional open surgeries. For instance, minimally invasive procedures have shown considerable benefits, with many surgeons performing over 100 endoscopies annually. As technology has advanced, devices such as balloon angioplasty catheters, stents, and thrombectomy tools have been refined to support less invasive techniques. This trend is leading to an increasing adoption of these devices in the treatment of peripheral vascular diseases, which are less disruptive to patients’ daily lives and improve overall outcomes.
Focus on Bioresorbable Vascular Devices
Another notable trend is the development of bioresorbable vascular devices. These innovative products, such as bioresorbable stents and scaffolds, are designed to dissolve naturally in the body over time, reducing the risk of long-term complications and the need for additional surgeries. Bioresorbable devices are gaining attention due to their ability to offer temporary support to vessels while promoting natural healing. For instance, the U.S. bioresorbable coronary stents market is projected to grow significantly, reflecting the increasing demand for safer, more effective treatment options. As the demand for safer, more effective treatment options grows, the trend toward bioresorbable devices is expected to drive market growth.
Increased Adoption of Drug-Eluting Stents
Drug-eluting stents (DES) have become a critical innovation in the treatment of peripheral artery disease (PAD). These stents are coated with medication that helps prevent the re-narrowing of the artery, reducing the risk of restenosis. The U.S. market is witnessing a shift toward the adoption of DES, driven by their ability to deliver better long-term outcomes for patients. As physicians and healthcare providers increasingly recognize the benefits of these stents, their adoption rate is expected to rise, further advancing the market for peripheral vascular devices.
Expansion of Outpatient and Ambulatory Care Settings
A growing trend in the U.S. healthcare landscape is the shift toward outpatient and ambulatory care centers for vascular procedures. With advancements in vascular device technologies and procedural techniques, more peripheral vascular interventions are being conducted in outpatient settings rather than hospitals. This shift is driven by cost-effectiveness, shorter recovery times, and patient convenience. As outpatient clinics and surgical centers expand their capabilities, they are contributing to the growing demand for peripheral vascular devices, driving market growth in these alternative care settings.
Market Challenges Analysis
High Cost of Peripheral Vascular Devices
One of the significant challenges facing the U.S. Peripheral Vascular Devices market is the high cost of advanced devices. Many peripheral vascular interventions, including stents, balloons, and catheters, require substantial financial investments in research, development, and manufacturing. For instance, the development of new stent technologies involves extensive clinical trials and regulatory approvals, which contribute to the high costs. These costs are often passed on to healthcare providers and patients, making treatments less affordable, especially for those without adequate insurance coverage. Although the growing demand for these devices is helping to offset some of these expenses, the high price remains a barrier, limiting access to treatment for certain patient populations. Moreover, the introduction of innovative but expensive technologies, such as bioresorbable stents and drug-eluting devices, further exacerbates the cost burden, presenting a significant challenge to widespread adoption.
Regulatory and Reimbursement Challenges
The regulatory landscape for peripheral vascular devices is another challenge that the market faces. The approval process for new devices is complex, requiring extensive clinical trials and data to meet the standards set by regulatory bodies such as the FDA. These lengthy and costly procedures can delay the introduction of new technologies to the market, slowing down innovation. Furthermore, reimbursement policies for peripheral vascular procedures are subject to change, and coverage may vary across insurers. Inconsistent reimbursement rates can discourage healthcare providers from adopting newer technologies or limit patient access to treatments. As a result, navigating regulatory requirements and ensuring consistent reimbursement remains a significant hurdle for companies in the peripheral vascular device market.
Market Opportunities
Growing Demand for Non-Invasive and Advanced Treatment Options
The U.S. Peripheral Vascular Devices market presents significant opportunities driven by the growing demand for non-invasive and advanced treatment options. As healthcare continues to shift towards less invasive procedures, there is an increasing need for devices that support minimally invasive treatments for peripheral artery disease (PAD) and other vascular conditions. Technological advancements, such as drug-eluting stents, bioresorbable scaffolds, and next-generation catheters, are opening up new opportunities for companies to develop and introduce innovative solutions. These advanced devices not only improve treatment outcomes but also reduce recovery times and minimize complications, positioning them as attractive options for healthcare providers and patients. The continued development of cutting-edge technologies in this space offers substantial growth potential, particularly as patient preferences shift towards procedures with fewer risks and shorter recovery periods.
Expansion into Outpatient and Ambulatory Care Settings
Another significant market opportunity lies in the expansion of peripheral vascular device use in outpatient and ambulatory care settings. As more peripheral vascular procedures move from hospitals to outpatient clinics and ambulatory surgical centers, the demand for affordable, efficient, and effective devices is rising. These care settings offer cost-effective alternatives to traditional hospital-based treatments, benefiting both patients and healthcare systems. Companies that can adapt their devices to meet the specific needs of outpatient care, such as reducing procedure times and simplifying device usage, will likely see increased adoption. Moreover, as healthcare facilities continue to embrace these settings for peripheral vascular interventions, the market for related devices is poised for growth, presenting a promising opportunity for manufacturers in this sector.
Market Segmentation Analysis:
By Type:
The U.S. Peripheral Vascular Devices market is segmented by type, with angioplasty balloons, angioplasty stents, catheters, guidewires, and other devices forming the key categories. Angioplasty balloons and angioplasty stents hold the largest market share, driven by their crucial role in treating peripheral artery disease (PAD). These devices are used to open blocked arteries and prevent restenosis, improving blood flow and reducing complications. Catheters and guidewires are essential for vascular interventions, enabling physicians to navigate arteries and deliver treatments effectively. These devices continue to see widespread use due to their versatility in a range of vascular procedures. Additionally, the “Others” category includes a variety of specialized devices such as thrombectomy tools, used for clot removal, and bioresorbable devices, which are gaining traction for their ability to support vessel healing without long-term implants. The growing preference for minimally invasive techniques is driving the demand for these devices, which is expected to continue to fuel market growth in the coming years.
By End-user:
The U.S. Peripheral Vascular Devices market is also segmented based on end-users, including hospitals, ambulatory surgical centers (ASCs), and specialty clinics. Hospitals remain the dominant end-user segment due to their large-scale infrastructure and comprehensive treatment capabilities. However, ambulatory surgical centers are rapidly gaining market share as healthcare shifts toward outpatient care. These centers offer cost-effective alternatives to traditional hospital settings, providing patients with quicker recovery times and lower treatment costs. Specialty clinics, which focus on vascular conditions, are also experiencing growth, as they provide specialized care and advanced treatment options for patients with peripheral vascular diseases. The expansion of outpatient and specialized care settings is reshaping the market landscape, presenting opportunities for manufacturers to tailor their devices for use in these environments. As more procedures move out of hospitals, the demand for efficient, easy-to-use devices suitable for outpatient settings is expected to rise, supporting the continued growth of these segments.
Segments:
Based on Type:
- Angioplasty Balloons
- Angioplasty Stents
- Catheters
- Guidewires
- Others
Based on End-user:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
Based on the Geography:
- Western United States
- Midwestern United States
- Southern United States
- Northeastern United States
Regional Analysis
Western United States
The Western United States holds the largest market share of 33% in the U.S. Peripheral Vascular Devices market, driven by the region’s advanced healthcare infrastructure, high adoption of new medical technologies, and a significant elderly population prone to vascular diseases. States such as California, Washington, and Oregon have some of the highest concentrations of hospitals, outpatient surgical centers, and specialty clinics, contributing to the increased demand for peripheral vascular devices. Additionally, the region is home to several key medical device manufacturers and research institutions, further driving innovation and market growth. The Western U.S. also benefits from a growing focus on minimally invasive procedures, such as angioplasty, which are increasingly preferred due to shorter recovery times and reduced risks, thereby supporting further expansion of the market.
Southern United States
The Southern United States represents 28% of the market share in the U.S. Peripheral Vascular Devices market. This region has a high prevalence of lifestyle-related risk factors such as obesity, diabetes, and hypertension, which are leading contributors to peripheral artery disease (PAD). States like Texas, Florida, and Georgia have a large aging population, which further drives the need for vascular treatments. The Southern U.S. has seen significant investments in healthcare facilities and outpatient care centers, expanding the accessibility of advanced vascular treatments. As healthcare policies in this region continue to evolve and access to cutting-edge medical technologies improves, the demand for peripheral vascular devices is expected to grow, providing opportunities for market players.
Northeastern United States
The Northeastern United States holds 22% of the U.S. Peripheral Vascular Devices market share, with states like New York, Massachusetts, and Pennsylvania being key contributors. This region boasts some of the leading hospitals and medical institutions in the country, supporting the high adoption of advanced medical technologies. The Northeastern U.S. has a large, diverse population with a growing number of elderly individuals, which increases the demand for treatments related to vascular diseases. The region also leads in research and development, with a focus on innovation in vascular devices such as drug-eluting stents and bioresorbable scaffolds. As the healthcare sector continues to expand, the market for peripheral vascular devices is expected to experience continued growth in this region.
Midwestern United States
The Midwestern United States, accounting for 17% of the market share, is witnessing steady growth in the peripheral vascular devices market. This region has a high incidence of PAD, which is directly influencing the demand for vascular interventions. States such as Illinois, Ohio, and Michigan are focusing on improving healthcare access, especially in rural areas, where the adoption of peripheral vascular devices is gaining traction. With an increasing number of outpatient surgical centers and specialty clinics offering advanced vascular treatments, the demand for devices like angioplasty balloons, stents, and catheters is on the rise. The growing focus on preventive healthcare and early diagnosis is likely to drive further expansion in the market for peripheral vascular devices across the Midwest.
Key Player Analysis
- Abbott Laboratories
- Boston Scientific Corporation
- Medtronic plc
- Terumo Corporation
- Becton, Dickinson and Company
- Cardinal Health
- Cook Medical
- Koninklijke Philips N.V.
- AngioDynamics, Inc.
- Biotronik SE & Co. KG
Competitive Analysis
The competitive landscape of the U.S. Peripheral Vascular Devices market is dominated by leading players such as Abbott Laboratories, Boston Scientific Corporation, Medtronic plc, Terumo Corporation, Becton, Dickinson and Company, Cardinal Health, Cook Medical, Koninklijke Philips N.V., AngioDynamics, Inc., and Biotronik SE & Co. KG. These players are focused on product development and technological advancements to meet the increasing demand for minimally invasive treatments. For instance, Abbott Laboratories has been actively involved in developing advanced vascular devices, including drug-eluting stents and bioresorbable scaffolds. Companies are introducing new devices, such as drug-eluting stents, bioresorbable scaffolds, and advanced catheters, to enhance treatment efficacy and improve patient outcomes. Strategic partnerships, mergers, and acquisitions are common strategies used to expand product portfolios and strengthen market positions. Additionally, companies are increasingly focusing on enhancing their presence in outpatient surgical centers and specialty clinics, responding to the growing trend of moving vascular procedures from hospitals to more cost-effective settings. The development of devices catering to both inpatient and outpatient care settings is crucial for staying competitive. Market players also emphasize research and development to address specific patient needs and offer customized solutions, creating differentiation in an increasingly saturated market. The competitive landscape is expected to remain dynamic, with continuous innovation and collaboration driving growth in the peripheral vascular devices sector.
Recent Developments
- In December 2024, Terumo Interventional Systems launched the R2P™ NaviCross® peripheral support catheter in the U.S. This catheter is designed for enhanced performance in radial-to-peripheral procedures, addressing the need for advanced tools in treating PAD and critical limb ischemia.
- In October 2024, BD was highlighted as a key player in the peripheral vascular devices market forecast report. While specific recent product launches were not detailed, BD’s ongoing commitment to R&D and innovation positions it strongly within this competitive landscape.
- In June 2023, Cook Medical announced new size options for its Advance Serenity PTA Balloon Catheter, used for treating peripheral artery disease (PAD).
- In June 2023, Biotronik launched the Oscar multifunctional peripheral catheter, designed for dilation of stenotic segments in peripheral vessels. The device features user-adjustable components and aims to improve procedural efficiency in treating peripheral arterial disease.
Market Concentration & Characteristics
The U.S. Peripheral Vascular Devices market exhibits a moderately concentrated structure, dominated by a few key players who lead in innovation and market share. These companies focus on product development and technological advancements, such as drug-eluting stents, bioresorbable scaffolds, and next-generation catheters, to maintain their competitive edge. Despite the dominance of large players, there is also room for smaller, specialized companies that focus on niche products or innovative solutions, especially in areas like imaging technologies and specialized vascular interventions. The market is characterized by rapid technological advancements, with ongoing research and development driving the introduction of novel devices that offer improved clinical outcomes and reduced procedural risks. Additionally, there is a notable trend toward the increasing shift of peripheral vascular procedures to outpatient settings, which is reshaping the market dynamics. Companies are adapting their strategies to provide devices that cater to both inpatient and outpatient care environments, enabling broader market access. Furthermore, regulatory requirements and pricing pressures play a crucial role in shaping the market’s characteristics, influencing product development cycles and the overall competitive landscape. The market’s concentration and the pace of innovation ensure continued growth, although smaller companies may face challenges related to market entry and scalability.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
Report Coverage
The research report offers an in-depth analysis based on Type, End-user and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook
- The market will see increased investment in research and development, especially in bioresorbable and drug-eluting devices, to address complex vascular conditions.
- Advancements in imaging technologies will enhance the accuracy of peripheral vascular procedures, contributing to better clinical outcomes.
- There will be growing adoption of AI and robotics in vascular procedures, improving procedural efficiency and reducing complications.
- The aging population in the U.S. will continue to be a major factor in driving demand for peripheral vascular devices as older adults are more prone to vascular diseases.
- Increasing focus on personalized medicine will lead to the development of devices tailored to individual patient needs and specific vascular conditions.
- The rise of telemedicine and remote monitoring will complement peripheral vascular treatments, providing ongoing care and enhancing patient management post-procedure.
- Regulatory bodies will likely streamline approval processes for new vascular devices, expediting their introduction to the market.
- As healthcare systems push for more cost-effective solutions, manufacturers will invest in developing affordable devices without compromising quality.
- The integration of digital health solutions into vascular treatments will continue to grow, improving patient outcomes and providing real-time monitoring capabilities.
- Expansion into emerging markets may become a priority for key players to capitalize on the growing demand for vascular interventions globally.